These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 9508338)

  • 1. Increased mast cell density in invasive melanoma.
    Duncan LM; Richards LA; Mihm MC
    J Cutan Pathol; 1998 Jan; 25(1):11-5. PubMed ID: 9508338
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of the mast cell growth factor interleukin-3 in melanocytic lesions correlates with an increased number of mast cells in the perilesional stroma: implications for melanoma progression.
    Reed JA; McNutt NS; Bogdany JK; Albino AP
    J Cutan Pathol; 1996 Dec; 23(6):495-505. PubMed ID: 9001979
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low numbers of tryptase+ and chymase+ mast cells associated with reduced survival and advanced tumor stage in melanoma.
    Siiskonen H; Poukka M; Bykachev A; Tyynelä-Korhonen K; Sironen R; Pasonen-Seppänen S; Harvima IT
    Melanoma Res; 2015 Dec; 25(6):479-85. PubMed ID: 26317168
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mast cells in melanocytic skin lesions. An immunohistochemical and quantitative study.
    Dyduch G; Okoń K; Pescarini E
    Pol J Pathol; 2011 Sep; 62(3):139-44. PubMed ID: 22102069
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Benign melanocytic lesions: risk markers or precursors of cutaneous melanoma?
    Skender-Kalnenas TM; English DR; Heenan PJ
    J Am Acad Dermatol; 1995 Dec; 33(6):1000-7. PubMed ID: 7490345
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The neuropeptide/mast cell secretagogue substance P is expressed in cutaneous melanocytic lesions.
    Khare VK; Albino AP; Reed JA
    J Cutan Pathol; 1998 Jan; 25(1):2-10. PubMed ID: 9508337
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cutaneous malignant melanoma: correlation between neovascularization and peritumor accumulation of mast cells overexpressing vascular endothelial growth factor.
    Tóth-Jakatics R; Jimi S; Takebayashi S; Kawamoto N
    Hum Pathol; 2000 Aug; 31(8):955-60. PubMed ID: 10987256
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Atypical melanocytic nevi of the genital type with a discussion of reciprocal parenchymal-stromal interactions in the biology of neoplasia.
    Clark WH; Hood AF; Tucker MA; Jampel RM
    Hum Pathol; 1998 Jan; 29(1 Suppl 1):S1-24. PubMed ID: 9445124
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A subgroup of melanocytic nevi on the distal lower extremity (ankle) shares features of acral nevi, dysplastic nevi, and melanoma in situ: a potential misdiagnosis of melanoma in situ.
    Khalifeh I; Taraif S; Reed JA; Lazar AF; Diwan AH; Prieto VG
    Am J Surg Pathol; 2007 Jul; 31(7):1130-6. PubMed ID: 17592281
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Problems with lesions related to the development of malignant melanoma: common nevi, dysplastic nevi, malignant melanoma in situ, and radial growth phase malignant melanoma.
    Clark WH; Tucker MA
    Hum Pathol; 1998 Jan; 29(1):8-14. PubMed ID: 9445128
    [No Abstract]   [Full Text] [Related]  

  • 11. Mast cells in melanocytic tumours.
    Schadendorf D; Kohlmus C; Gawlik C; Suter L; Czarnetzki BM
    Arch Dermatol Res; 1995; 287(5):452-6. PubMed ID: 7625856
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Morphometric analysis of melanocytic tumors. A study of nuclear area and density.
    Boivin C; Thomine E; Menard JF; Bigorgne C; Hemet J
    Am J Dermatopathol; 1994 Apr; 16(2):145-9. PubMed ID: 8030766
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antigenic profile of tumor progression stages in human melanocytic nevi and melanomas.
    Elder DE; Rodeck U; Thurin J; Cardillo F; Clark WH; Stewart R; Herlyn M
    Cancer Res; 1989 Sep; 49(18):5091-6. PubMed ID: 2548711
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prediction of histologic melanocytic dysplasia from clinical observation.
    Roush GC; Dubin N; Barnhill RL
    J Am Acad Dermatol; 1993 Oct; 29(4):555-62. PubMed ID: 8408790
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of In Vivo Reflectance Confocal Microscopy in the Analysis of Melanocytic Lesions.
    Serban ED; Farnetani F; Pellacani G; Constantin MM
    Acta Dermatovenerol Croat; 2018 Apr; 26(1):64-67. PubMed ID: 29782304
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association between melanoma and dermal mast cell prevalence in sun-unexposed skin.
    Grimbaldeston MA; Pearce AL; Robertson BO; Coventry BJ; Marshman G; Finlay-Jones JJ; Hart PH
    Br J Dermatol; 2004 May; 150(5):895-903. PubMed ID: 15149501
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Rare melanocytes and nevus-cell nevi].
    Frenk E; Mevorah B; Delacrétaz J
    Hautarzt; 1975 Dec; 26(12):619-24. PubMed ID: 1213881
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lymphatic vessel density is significantly increased in melanoma.
    Giorgadze TA; Zhang PJ; Pasha T; Coogan PS; Acs G; Elder DE; Xu X
    J Cutan Pathol; 2004 Nov; 31(10):672-7. PubMed ID: 15491327
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Morphometric, DNA, and proliferating cell nuclear antigen measurements in benign melanocytic lesions and cutaneous malignant melanoma.
    Björnhagen V; Bonfoco E; Brahme EM; Lindholm J; Auer G
    Am J Dermatopathol; 1994 Dec; 16(6):615-23. PubMed ID: 7864299
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Melanocytic nevi and tumor progression: perspectives concerning histomorphology, melanoma risk and molecular genetics.
    Barnhill RL
    Dermatology; 1993; 187(2):86-90. PubMed ID: 8358111
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.